Outstanding Job to Jack Walker on Getting Published!
In January 2020, Jack Walker (Powers lab) published a co-first author paper titled, “Tacrolimus- and sirolimus-induced human beta cell dysfunction is reversible and preventable” in JCI Insight 5(1).
He also published a co-first author paper titled, “Integrated human pseudoislet system and microfluidic platform demonstrate differences in GPCR signaling in islet cells” in JCI Insight 5(10) in May 2020.
In August 2020, he also published a paper titled, “Dapagliflozin Does Not Directly Affect Human α or β cells in Endocrinology 161(8).